Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16th and 17th. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making Dr. Schneider’s presentation focused on a conceptual framework for exploring the economic aspects of cancer…
read more
Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16-17, organized by Abbott Diagnostics. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making.”
https://avalonecon.com/wp-content/themes/fildisi/images/empty/thumbnail.jpg
150
150
Avalon Health Economics LLC
https://avalonecon.com/wp-content/themes/fildisi/images/empty/thumbnail.jpg